The researchers evaluated 46 patients who underwent implantation of X-Stop interspinous spacer for treating neurogenic claudication with an average follow-up of 40 months. They found the revision rate at 30.4 percent and discovered:
• Lack of improvement at six-week follow up was correlated with revision surgery.
• Revision procedures predominantly took place 12 months after the index surgery.
• Patients who didn’t need revision surgery experienced significant improvement in clinical outcomes.
• Implant survival rate probability was 0.68 on the Kaplan-Meier survivorship analysis at 48 months postoperatively.
The authors suggested patient selection could be a reason for early revision surgery.
More Articles on Spine Surgery:
5 Characteristics Associated With Spine Surgery Complications
How Can Spine Surgeons See High ROI From Marketing
Where is Spinal Fusion Headed? Q&A With Dr. Mark Crawford of ABQ Health
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
